Varigen Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Varigen Biosciences's estimated annual revenue is currently $1.9M per year.
- Varigen Biosciences's estimated revenue per employee is $155,000
Employee Data
- Varigen Biosciences has 12 Employees.
- Varigen Biosciences grew their employee count by -8% last year.
Varigen Biosciences's People
Name | Title | Email/Phone |
---|
Varigen Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Varigen Biosciences?
Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways. Learn about our DNAtrapâ„¢ custom cloning service which delivers verified clones of your DNA target (up to 100 kb) in just 10 days at http://varigenbiosciences.com/dnatrap-custom-cloning-service/. Learn about how our BigDNAâ„¢ metagenomics libraries can revolutionize natural product discovery at http://varigenbiosciences.com/products/.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Varigen Biosciences News
2022-04-06 - The metagenomic sequencing market is expected to reach USD 4.3 billion by
2027 from USD 1.9 billion in 2022, at a CAGR of 18.4%
(Switzerland), Varigen Biosciences (US), Veritas Genetics (US), SinGENE (Singapore), Intact Genomics, Inc., Metagenomi (US),...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 12 | 33% | N/A |
#2 | $3M | 12 | N/A | N/A |
#3 | N/A | 12 | 50% | N/A |
#4 | $1M | 12 | 9% | N/A |
#5 | $1.3M | 12 | 9% | N/A |